Global Infectious Disease Rapid Diagnostic Testing Market Research Report 2025(Status and Outlook)
Report Overview
The global Infectious Disease Rapid Diagnostic Testing market size was estimated at USD 12450.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease Rapid Diagnostic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease Rapid Diagnostic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease Rapid Diagnostic Testing market
Global Infectious Disease Rapid Diagnostic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Roche Ltd
Danaher Corporation
Luminex Corporation
BGI Group
bioMerieux S.A.
DiaSorin S.p.A
HologicInc.
Mesa Biotech
Quidel Corporation
Thermo Fisher Scientific Inc.
GenMark Diagnostics
CTK Biotech
Becton Dickinson
Cellex Inc.
Market Segmentation (by Type)
Assays
Platforms
Market Segmentation (by Application)
Respiratory Infection
Gastro-Intestinal Infection
Center Nervous System Infection
Hospital Acquired Infection
Sexually Transmitted Infections
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Rapid Diagnostic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Rapid Diagnostic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Infectious Disease Rapid Diagnostic Testing market size was estimated at USD 12450.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Infectious Disease Rapid Diagnostic Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Infectious Disease Rapid Diagnostic Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease Rapid Diagnostic Testing market
Global Infectious Disease Rapid Diagnostic Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Roche Ltd
Danaher Corporation
Luminex Corporation
BGI Group
bioMerieux S.A.
DiaSorin S.p.A
HologicInc.
Mesa Biotech
Quidel Corporation
Thermo Fisher Scientific Inc.
GenMark Diagnostics
CTK Biotech
Becton Dickinson
Cellex Inc.
Market Segmentation (by Type)
Assays
Platforms
Market Segmentation (by Application)
Respiratory Infection
Gastro-Intestinal Infection
Center Nervous System Infection
Hospital Acquired Infection
Sexually Transmitted Infections
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Infectious Disease Rapid Diagnostic Testing Market
- Overview of the regional outlook of the Infectious Disease Rapid Diagnostic Testing Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Rapid Diagnostic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Infectious Disease Rapid Diagnostic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Infectious Disease Rapid Diagnostic Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Rapid Diagnostic Testing Segment by Type
1.2.2 Infectious Disease Rapid Diagnostic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Infectious Disease Rapid Diagnostic Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease Rapid Diagnostic Testing Product Life Cycle
3.3 Global Infectious Disease Rapid Diagnostic Testing Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease Rapid Diagnostic Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease Rapid Diagnostic Testing Market Competitive Situation and Trends
3.8.1 Infectious Disease Rapid Diagnostic Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease Rapid Diagnostic Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Rapid Diagnostic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease Rapid Diagnostic Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Rapid Diagnostic Testing Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2020-2025)
6.4 Global Infectious Disease Rapid Diagnostic Testing Price by Type (2020-2025)
7 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Rapid Diagnostic Testing Market Sales by Application (2020-2025)
7.3 Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease Rapid Diagnostic Testing Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SALES BY REGION
8.1 Global Infectious Disease Rapid Diagnostic Testing Sales by Region
8.1.1 Global Infectious Disease Rapid Diagnostic Testing Sales by Region
8.1.2 Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region
8.2 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.2.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Infectious Disease Rapid Diagnostic Testing Sales by Country
8.3.2 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease Rapid Diagnostic Testing Sales by Country
8.4.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales by Region
8.5.2 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease Rapid Diagnostic Testing Sales by Country
8.6.2 South America Infectious Disease Rapid Diagnostic Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales by Region
8.7.2 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease Rapid Diagnostic Testing by Region(2020-2025)
9.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease Rapid Diagnostic Testing Production
9.4.1 North America Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease Rapid Diagnostic Testing Production
9.5.1 Europe Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease Rapid Diagnostic Testing Production (2020-2025)
9.6.1 Japan Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease Rapid Diagnostic Testing Production (2020-2025)
9.7.1 China Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Overview
10.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Roche Ltd
10.2.1 Roche Ltd Basic Information
10.2.2 Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Overview
10.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.2.4 Roche Ltd Business Overview
10.2.5 Roche Ltd SWOT Analysis
10.2.6 Roche Ltd Recent Developments
10.3 Danaher Corporation
10.3.1 Danaher Corporation Basic Information
10.3.2 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
10.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.3.4 Danaher Corporation Business Overview
10.3.5 Danaher Corporation SWOT Analysis
10.3.6 Danaher Corporation Recent Developments
10.4 Luminex Corporation
10.4.1 Luminex Corporation Basic Information
10.4.2 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
10.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.4.4 Luminex Corporation Business Overview
10.4.5 Luminex Corporation Recent Developments
10.5 BGI Group
10.5.1 BGI Group Basic Information
10.5.2 BGI Group Infectious Disease Rapid Diagnostic Testing Product Overview
10.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.5.4 BGI Group Business Overview
10.5.5 BGI Group Recent Developments
10.6 bioMerieux S.A.
10.6.1 bioMerieux S.A. Basic Information
10.6.2 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Overview
10.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.6.4 bioMerieux S.A. Business Overview
10.6.5 bioMerieux S.A. Recent Developments
10.7 DiaSorin S.p.A
10.7.1 DiaSorin S.p.A Basic Information
10.7.2 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Overview
10.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.7.4 DiaSorin S.p.A Business Overview
10.7.5 DiaSorin S.p.A Recent Developments
10.8 HologicInc.
10.8.1 HologicInc. Basic Information
10.8.2 HologicInc. Infectious Disease Rapid Diagnostic Testing Product Overview
10.8.3 HologicInc. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.8.4 HologicInc. Business Overview
10.8.5 HologicInc. Recent Developments
10.9 Mesa Biotech
10.9.1 Mesa Biotech Basic Information
10.9.2 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
10.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.9.4 Mesa Biotech Business Overview
10.9.5 Mesa Biotech Recent Developments
10.10 Quidel Corporation
10.10.1 Quidel Corporation Basic Information
10.10.2 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
10.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.10.4 Quidel Corporation Business Overview
10.10.5 Quidel Corporation Recent Developments
10.11 Thermo Fisher Scientific Inc.
10.11.1 Thermo Fisher Scientific Inc. Basic Information
10.11.2 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
10.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.11.4 Thermo Fisher Scientific Inc. Business Overview
10.11.5 Thermo Fisher Scientific Inc. Recent Developments
10.12 GenMark Diagnostics
10.12.1 GenMark Diagnostics Basic Information
10.12.2 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Overview
10.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.12.4 GenMark Diagnostics Business Overview
10.12.5 GenMark Diagnostics Recent Developments
10.13 CTK Biotech
10.13.1 CTK Biotech Basic Information
10.13.2 CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
10.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.13.4 CTK Biotech Business Overview
10.13.5 CTK Biotech Recent Developments
10.14 Becton Dickinson
10.14.1 Becton Dickinson Basic Information
10.14.2 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Overview
10.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.14.4 Becton Dickinson Business Overview
10.14.5 Becton Dickinson Recent Developments
10.15 Cellex Inc.
10.15.1 Cellex Inc. Basic Information
10.15.2 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
10.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.15.4 Cellex Inc. Business Overview
10.15.5 Cellex Inc. Recent Developments
11 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET FORECAST BY REGION
11.1 Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast
11.2 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Region
11.2.4 South America Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Rapid Diagnostic Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Infectious Disease Rapid Diagnostic Testing by Type (2026-2033)
12.1.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Infectious Disease Rapid Diagnostic Testing by Type (2026-2033)
12.2 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Application (2026-2033)
12.2.1 Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Infectious Disease Rapid Diagnostic Testing
1.2 Key Market Segments
1.2.1 Infectious Disease Rapid Diagnostic Testing Segment by Type
1.2.2 Infectious Disease Rapid Diagnostic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Infectious Disease Rapid Diagnostic Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Infectious Disease Rapid Diagnostic Testing Product Life Cycle
3.3 Global Infectious Disease Rapid Diagnostic Testing Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease Rapid Diagnostic Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease Rapid Diagnostic Testing Market Competitive Situation and Trends
3.8.1 Infectious Disease Rapid Diagnostic Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Infectious Disease Rapid Diagnostic Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Infectious Disease Rapid Diagnostic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease Rapid Diagnostic Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Rapid Diagnostic Testing Market
5.7 ESG Ratings of Leading Companies
6 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Type (2020-2025)
6.4 Global Infectious Disease Rapid Diagnostic Testing Price by Type (2020-2025)
7 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Rapid Diagnostic Testing Market Sales by Application (2020-2025)
7.3 Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease Rapid Diagnostic Testing Sales Growth Rate by Application (2020-2025)
8 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET SALES BY REGION
8.1 Global Infectious Disease Rapid Diagnostic Testing Sales by Region
8.1.1 Global Infectious Disease Rapid Diagnostic Testing Sales by Region
8.1.2 Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region
8.2 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.2.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Infectious Disease Rapid Diagnostic Testing Sales by Country
8.3.2 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Infectious Disease Rapid Diagnostic Testing Sales by Country
8.4.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales by Region
8.5.2 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Infectious Disease Rapid Diagnostic Testing Sales by Country
8.6.2 South America Infectious Disease Rapid Diagnostic Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales by Region
8.7.2 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Infectious Disease Rapid Diagnostic Testing by Region(2020-2025)
9.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease Rapid Diagnostic Testing Production
9.4.1 North America Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.4.2 North America Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease Rapid Diagnostic Testing Production
9.5.1 Europe Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.5.2 Europe Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease Rapid Diagnostic Testing Production (2020-2025)
9.6.1 Japan Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.6.2 Japan Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease Rapid Diagnostic Testing Production (2020-2025)
9.7.1 China Infectious Disease Rapid Diagnostic Testing Production Growth Rate (2020-2025)
9.7.2 China Infectious Disease Rapid Diagnostic Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Overview
10.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 Roche Ltd
10.2.1 Roche Ltd Basic Information
10.2.2 Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Overview
10.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.2.4 Roche Ltd Business Overview
10.2.5 Roche Ltd SWOT Analysis
10.2.6 Roche Ltd Recent Developments
10.3 Danaher Corporation
10.3.1 Danaher Corporation Basic Information
10.3.2 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
10.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.3.4 Danaher Corporation Business Overview
10.3.5 Danaher Corporation SWOT Analysis
10.3.6 Danaher Corporation Recent Developments
10.4 Luminex Corporation
10.4.1 Luminex Corporation Basic Information
10.4.2 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
10.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.4.4 Luminex Corporation Business Overview
10.4.5 Luminex Corporation Recent Developments
10.5 BGI Group
10.5.1 BGI Group Basic Information
10.5.2 BGI Group Infectious Disease Rapid Diagnostic Testing Product Overview
10.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.5.4 BGI Group Business Overview
10.5.5 BGI Group Recent Developments
10.6 bioMerieux S.A.
10.6.1 bioMerieux S.A. Basic Information
10.6.2 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Overview
10.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.6.4 bioMerieux S.A. Business Overview
10.6.5 bioMerieux S.A. Recent Developments
10.7 DiaSorin S.p.A
10.7.1 DiaSorin S.p.A Basic Information
10.7.2 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Overview
10.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.7.4 DiaSorin S.p.A Business Overview
10.7.5 DiaSorin S.p.A Recent Developments
10.8 HologicInc.
10.8.1 HologicInc. Basic Information
10.8.2 HologicInc. Infectious Disease Rapid Diagnostic Testing Product Overview
10.8.3 HologicInc. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.8.4 HologicInc. Business Overview
10.8.5 HologicInc. Recent Developments
10.9 Mesa Biotech
10.9.1 Mesa Biotech Basic Information
10.9.2 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
10.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.9.4 Mesa Biotech Business Overview
10.9.5 Mesa Biotech Recent Developments
10.10 Quidel Corporation
10.10.1 Quidel Corporation Basic Information
10.10.2 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
10.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.10.4 Quidel Corporation Business Overview
10.10.5 Quidel Corporation Recent Developments
10.11 Thermo Fisher Scientific Inc.
10.11.1 Thermo Fisher Scientific Inc. Basic Information
10.11.2 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
10.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.11.4 Thermo Fisher Scientific Inc. Business Overview
10.11.5 Thermo Fisher Scientific Inc. Recent Developments
10.12 GenMark Diagnostics
10.12.1 GenMark Diagnostics Basic Information
10.12.2 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Overview
10.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.12.4 GenMark Diagnostics Business Overview
10.12.5 GenMark Diagnostics Recent Developments
10.13 CTK Biotech
10.13.1 CTK Biotech Basic Information
10.13.2 CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
10.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.13.4 CTK Biotech Business Overview
10.13.5 CTK Biotech Recent Developments
10.14 Becton Dickinson
10.14.1 Becton Dickinson Basic Information
10.14.2 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Overview
10.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.14.4 Becton Dickinson Business Overview
10.14.5 Becton Dickinson Recent Developments
10.15 Cellex Inc.
10.15.1 Cellex Inc. Basic Information
10.15.2 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
10.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Market Performance
10.15.4 Cellex Inc. Business Overview
10.15.5 Cellex Inc. Recent Developments
11 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET FORECAST BY REGION
11.1 Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast
11.2 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country
11.2.3 Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Region
11.2.4 South America Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Rapid Diagnostic Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Infectious Disease Rapid Diagnostic Testing by Type (2026-2033)
12.1.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Infectious Disease Rapid Diagnostic Testing by Type (2026-2033)
12.2 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Application (2026-2033)
12.2.1 Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) Forecast by Application
12.2.2 Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Disease Rapid Diagnostic Testing Market Size Comparison by Region (M USD)
Table 5. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Infectious Disease Rapid Diagnostic Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2024)
Table 10. Global Market Infectious Disease Rapid Diagnostic Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Infectious Disease Rapid Diagnostic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Infectious Disease Rapid Diagnostic Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Infectious Disease Rapid Diagnostic Testing Sales by Type (K Units)
Table 26. Global Infectious Disease Rapid Diagnostic Testing Market Size by Type (M USD)
Table 27. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2020-2025)
Table 29. Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Infectious Disease Rapid Diagnostic Testing Market Size Share by Type (2020-2025)
Table 31. Global Infectious Disease Rapid Diagnostic Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) by Application
Table 33. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application
Table 34. Global Infectious Disease Rapid Diagnostic Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2020-2025)
Table 36. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application (2020-2025)
Table 38. Global Infectious Disease Rapid Diagnostic Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Infectious Disease Rapid Diagnostic Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region (2020-2025)
Table 41. Global Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Infectious Disease Rapid Diagnostic Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Infectious Disease Rapid Diagnostic Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Infectious Disease Rapid Diagnostic Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Infectious Disease Rapid Diagnostic Testing Production (K Units) by Region(2020-2025)
Table 54. Global Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Laboratories Basic Information
Table 62. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Overview
Table 63. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories SWOT Analysis
Table 66. Abbott Laboratories Recent Developments
Table 67. Roche Ltd Basic Information
Table 68. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Overview
Table 69. Roche Ltd Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Roche Ltd Business Overview
Table 71. Roche Ltd SWOT Analysis
Table 72. Roche Ltd Recent Developments
Table 73. Danaher Corporation Basic Information
Table 74. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
Table 75. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Danaher Corporation Business Overview
Table 77. Danaher Corporation SWOT Analysis
Table 78. Danaher Corporation Recent Developments
Table 79. Luminex Corporation Basic Information
Table 80. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
Table 81. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Luminex Corporation Business Overview
Table 83. Luminex Corporation Recent Developments
Table 84. BGI Group Basic Information
Table 85. BGI Group Infectious Disease Rapid Diagnostic Testing Product Overview
Table 86. BGI Group Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. BGI Group Business Overview
Table 88. BGI Group Recent Developments
Table 89. bioMerieux S.A. Basic Information
Table 90. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 91. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. bioMerieux S.A. Business Overview
Table 93. bioMerieux S.A. Recent Developments
Table 94. DiaSorin S.p.A Basic Information
Table 95. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Overview
Table 96. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. DiaSorin S.p.A Business Overview
Table 98. DiaSorin S.p.A Recent Developments
Table 99. HologicInc. Basic Information
Table 100. HologicInc. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 101. HologicInc. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. HologicInc. Business Overview
Table 103. HologicInc. Recent Developments
Table 104. Mesa Biotech Basic Information
Table 105. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
Table 106. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Mesa Biotech Business Overview
Table 108. Mesa Biotech Recent Developments
Table 109. Quidel Corporation Basic Information
Table 110. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
Table 111. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Quidel Corporation Business Overview
Table 113. Quidel Corporation Recent Developments
Table 114. Thermo Fisher Scientific Inc. Basic Information
Table 115. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 116. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Thermo Fisher Scientific Inc. Business Overview
Table 118. Thermo Fisher Scientific Inc. Recent Developments
Table 119. GenMark Diagnostics Basic Information
Table 120. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Overview
Table 121. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. GenMark Diagnostics Business Overview
Table 123. GenMark Diagnostics Recent Developments
Table 124. CTK Biotech Basic Information
Table 125. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
Table 126. CTK Biotech Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. CTK Biotech Business Overview
Table 128. CTK Biotech Recent Developments
Table 129. Becton Dickinson Basic Information
Table 130. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Overview
Table 131. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Becton Dickinson Business Overview
Table 133. Becton Dickinson Recent Developments
Table 134. Cellex Inc. Basic Information
Table 135. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 136. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Cellex Inc. Business Overview
Table 138. Cellex Inc. Recent Developments
Table 139. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Infectious Disease Rapid Diagnostic Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Infectious Disease Rapid Diagnostic Testing Market Size Comparison by Region (M USD)
Table 5. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Infectious Disease Rapid Diagnostic Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2024)
Table 10. Global Market Infectious Disease Rapid Diagnostic Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Infectious Disease Rapid Diagnostic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Infectious Disease Rapid Diagnostic Testing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Infectious Disease Rapid Diagnostic Testing Sales by Type (K Units)
Table 26. Global Infectious Disease Rapid Diagnostic Testing Market Size by Type (M USD)
Table 27. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) by Type (2020-2025)
Table 28. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Type (2020-2025)
Table 29. Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) by Type (2020-2025)
Table 30. Global Infectious Disease Rapid Diagnostic Testing Market Size Share by Type (2020-2025)
Table 31. Global Infectious Disease Rapid Diagnostic Testing Price (USD/Unit) by Type (2020-2025)
Table 32. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) by Application
Table 33. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application
Table 34. Global Infectious Disease Rapid Diagnostic Testing Sales by Application (2020-2025) & (K Units)
Table 35. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2020-2025)
Table 36. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application (2020-2025)
Table 38. Global Infectious Disease Rapid Diagnostic Testing Sales Growth Rate by Application (2020-2025)
Table 39. Global Infectious Disease Rapid Diagnostic Testing Sales by Region (2020-2025) & (K Units)
Table 40. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region (2020-2025)
Table 41. Global Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2020-2025)
Table 43. North America Infectious Disease Rapid Diagnostic Testing Sales by Country (2020-2025) & (K Units)
Table 44. North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Infectious Disease Rapid Diagnostic Testing Sales by Country (2020-2025) & (K Units)
Table 46. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Infectious Disease Rapid Diagnostic Testing Sales by Country (2020-2025) & (K Units)
Table 50. South America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Infectious Disease Rapid Diagnostic Testing Production (K Units) by Region(2020-2025)
Table 54. Global Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Region (2020-2025)
Table 56. Global Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Infectious Disease Rapid Diagnostic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Laboratories Basic Information
Table 62. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product Overview
Table 63. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories SWOT Analysis
Table 66. Abbott Laboratories Recent Developments
Table 67. Roche Ltd Basic Information
Table 68. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product Overview
Table 69. Roche Ltd Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Roche Ltd Business Overview
Table 71. Roche Ltd SWOT Analysis
Table 72. Roche Ltd Recent Developments
Table 73. Danaher Corporation Basic Information
Table 74. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
Table 75. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Danaher Corporation Business Overview
Table 77. Danaher Corporation SWOT Analysis
Table 78. Danaher Corporation Recent Developments
Table 79. Luminex Corporation Basic Information
Table 80. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
Table 81. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Luminex Corporation Business Overview
Table 83. Luminex Corporation Recent Developments
Table 84. BGI Group Basic Information
Table 85. BGI Group Infectious Disease Rapid Diagnostic Testing Product Overview
Table 86. BGI Group Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. BGI Group Business Overview
Table 88. BGI Group Recent Developments
Table 89. bioMerieux S.A. Basic Information
Table 90. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 91. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. bioMerieux S.A. Business Overview
Table 93. bioMerieux S.A. Recent Developments
Table 94. DiaSorin S.p.A Basic Information
Table 95. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product Overview
Table 96. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. DiaSorin S.p.A Business Overview
Table 98. DiaSorin S.p.A Recent Developments
Table 99. HologicInc. Basic Information
Table 100. HologicInc. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 101. HologicInc. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. HologicInc. Business Overview
Table 103. HologicInc. Recent Developments
Table 104. Mesa Biotech Basic Information
Table 105. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
Table 106. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Mesa Biotech Business Overview
Table 108. Mesa Biotech Recent Developments
Table 109. Quidel Corporation Basic Information
Table 110. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product Overview
Table 111. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Quidel Corporation Business Overview
Table 113. Quidel Corporation Recent Developments
Table 114. Thermo Fisher Scientific Inc. Basic Information
Table 115. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 116. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Thermo Fisher Scientific Inc. Business Overview
Table 118. Thermo Fisher Scientific Inc. Recent Developments
Table 119. GenMark Diagnostics Basic Information
Table 120. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product Overview
Table 121. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. GenMark Diagnostics Business Overview
Table 123. GenMark Diagnostics Recent Developments
Table 124. CTK Biotech Basic Information
Table 125. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product Overview
Table 126. CTK Biotech Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. CTK Biotech Business Overview
Table 128. CTK Biotech Recent Developments
Table 129. Becton Dickinson Basic Information
Table 130. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product Overview
Table 131. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Becton Dickinson Business Overview
Table 133. Becton Dickinson Recent Developments
Table 134. Cellex Inc. Basic Information
Table 135. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product Overview
Table 136. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Cellex Inc. Business Overview
Table 138. Cellex Inc. Recent Developments
Table 139. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 140. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 141. North America Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 142. North America Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 143. Europe Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 144. Europe Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 145. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Forecast by Region (2026-2033) & (K Units)
Table 146. Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Region (2026-2033) & (M USD)
Table 147. South America Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (K Units)
Table 148. South America Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales Forecast by Country (2026-2033) & (Units)
Table 150. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Type (2026-2033) & (K Units)
Table 152. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Type (2026-2033) & (M USD)
Table 153. Global Infectious Disease Rapid Diagnostic Testing Price Forecast by Type (2026-2033) & (USD/Unit)
Table 154. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) Forecast by Application (2026-2033)
Table 155. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Infectious Disease Rapid Diagnostic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD), 2024-2033
Figure 5. Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) (2020-2033)
Figure 6. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Rapid Diagnostic Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease Rapid Diagnostic Testing Product Life Cycle
Figure 13. Infectious Disease Rapid Diagnostic Testing Sales Share by Manufacturers in 2024
Figure 14. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Manufacturers in 2024
Figure 15. Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Infectious Disease Rapid Diagnostic Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Rapid Diagnostic Testing Revenue in 2024
Figure 18. Industry Chain Map of Infectious Disease Rapid Diagnostic Testing
Figure 19. Global Infectious Disease Rapid Diagnostic Testing Market PEST Analysis
Figure 20. Global Infectious Disease Rapid Diagnostic Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease Rapid Diagnostic Testing Market Share by Type
Figure 27. Sales Market Share of Infectious Disease Rapid Diagnostic Testing by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease Rapid Diagnostic Testing by Type in 2024
Figure 29. Market Size Share of Infectious Disease Rapid Diagnostic Testing by Type (2020-2025)
Figure 30. Market Size Share of Infectious Disease Rapid Diagnostic Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application
Figure 33. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application in 2024
Figure 35. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application in 2024
Figure 37. Global Infectious Disease Rapid Diagnostic Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease Rapid Diagnostic Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease Rapid Diagnostic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease Rapid Diagnostic Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease Rapid Diagnostic Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2024
Figure 55. Germany Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region in 2024
Figure 68. China Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease Rapid Diagnostic Testing Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Infectious Disease Rapid Diagnostic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD), 2024-2033
Figure 5. Global Infectious Disease Rapid Diagnostic Testing Market Size (M USD) (2020-2033)
Figure 6. Global Infectious Disease Rapid Diagnostic Testing Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Rapid Diagnostic Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease Rapid Diagnostic Testing Product Life Cycle
Figure 13. Infectious Disease Rapid Diagnostic Testing Sales Share by Manufacturers in 2024
Figure 14. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Manufacturers in 2024
Figure 15. Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Infectious Disease Rapid Diagnostic Testing Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Rapid Diagnostic Testing Revenue in 2024
Figure 18. Industry Chain Map of Infectious Disease Rapid Diagnostic Testing
Figure 19. Global Infectious Disease Rapid Diagnostic Testing Market PEST Analysis
Figure 20. Global Infectious Disease Rapid Diagnostic Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease Rapid Diagnostic Testing Market Share by Type
Figure 27. Sales Market Share of Infectious Disease Rapid Diagnostic Testing by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease Rapid Diagnostic Testing by Type in 2024
Figure 29. Market Size Share of Infectious Disease Rapid Diagnostic Testing by Type (2020-2025)
Figure 30. Market Size Share of Infectious Disease Rapid Diagnostic Testing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application
Figure 33. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Application in 2024
Figure 35. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application in 2024
Figure 37. Global Infectious Disease Rapid Diagnostic Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region (2020-2025)
Figure 40. North America Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2024
Figure 45. U.S. Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease Rapid Diagnostic Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease Rapid Diagnostic Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease Rapid Diagnostic Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease Rapid Diagnostic Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2024
Figure 55. Germany Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region in 2024
Figure 68. China Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease Rapid Diagnostic Testing Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Country in 2024
Figure 82. Brazil Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease Rapid Diagnostic Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease Rapid Diagnostic Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease Rapid Diagnostic Testing Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease Rapid Diagnostic Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Type (2026-2033)
Figure 111. Global Infectious Disease Rapid Diagnostic Testing Sales Forecast by Application (2026-2033)
Figure 112. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Application (2026-2033)
